Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

JAK2 Exon 12 Mutant Allele Burden Study (JETMABS): A European Multicenter Study

Lasse Kjaer, Ph.D., Eric Lippert, Francois Girodon, MD, PhD, Susanne Schnittger, PhD, Serge Carillo, Caroline Riley, MD, Beatriz Bellosillo, Maj K. Westman, Ole Weis Bjerrum, MD, Marzena Wojtaszewska, Thomas Kristensen, MSc, PhD, Melanie Percy, PhD, Mary Frances McMullin, MD, MRCPath, Maruska Marusic, Caroline Rosmond, Lars Palmqvist, MD, PhD, Sylvie Hermouet, MD, Ph.D., Hans Carl Hasselbalch, MD, DMSc

Blood (2013) 122 (21): 4075.

https://doi.org/10.1182/blood.V122.21.4075.4075

Published: 2013

Journal Articles

Polycythemia-Inducing Mutations In The Erythropoietin Receptor (EPOR): Mechanism and Function Elucidated By EGFR– EPOR Chimeras

Mor Gross, Nathalie Ben-Califa, PhD, Hans Carl Hasselbalch, MD, DMSc, Mary Frances McMullin, MD, Melanie Percy, PhD, Celeste Bento, MD, Holger Cario, MD, Milen Minkov, MD, PhD, Drorit Neumann, PhD

Blood (2013) 122 (21): 2174.

https://doi.org/10.1182/blood.V122.21.2174.2174

Published: 2013

Journal Articles

First Achievements of MPN&MPNr-EuroNet (COST Action BM0902), a New European Network Dedicated to the Diagnosis of Myeloproliferative Neoplasms and Hereditary Erythrocytosis and Thrombocytosis

Sylvie Hermouet, MD, PhD, Eric Lippert, PhD, Niels Pallisgaard, Jiri Schwarz, MD, PhD, Mary Frances McMullin, MD, Lars Palmqvist, MD, PhD, Heike L Pahl, Ph.D., Beatriz Bellosillo Paricio, Celeste Bento, Serge Carillo, Stephane Giraudier, MD, PhD, Francois Girodon, MD, PhD, Melanie Percy, PhD, FRCPath, Lukas Plank, Susanne Schnittger, PhD, Radek C. Skoda, MD, Alessandro M. Vannucchi, MD

Blood (2011) 118 (21): 2809.

https://doi.org/10.1182/blood.V118.21.2809.2809

Published: 2011

Journal Articles

The JAK2 46/1 Haplotype Predisposes to Myeloproliferative Neoplasms Characterized by Diverse Mutations.

Nicholas C.P. Cross, PhD, FRCPath, Peter Campbell, MD, PhD, Philip A Beer, BM, MRCP, MRCPath, Susanne Schnittger, PhD, Alessandro M. Vannucchi, MD, Katerina Zoi, PhD, Melanie Percy, PhD, FRCPath, Mary Frances McMullin, Linda Scott, BSc, PhD, Richard T. Silver, MD, David Oscier, MD, Claire Harrison, MD, Anthony R. Green, FRCP, FRCPath, FMed, Sci, Andrew Chase, PhD

Blood (2009) 114 (22): 433.

https://doi.org/10.1182/blood.V114.22.433.433

Published: 2009

Journal Articles

HIF-2alpha Associated Familial Erythrocytosis Supports the PHD2-HIF- 2alpha-VHL Axis as the Major Regulator of Erythropoietin Production

Melanie Percy, PhD, Paul W Furlow, Philip A Beer, BM, MRCP, MRCPath, Gavin Campbell, Adriaan W. Dekker, MD, Anthony R. Green, PhD, FRCP, FRCPath, Xiping Li, Scott Sutherland, David Oscier, M. Glenn Rainey, Enid Rivera, Richard van Wijk, Marion Wood, Terence R.J. Lappin, PhD, FRCPath, Mary Frances McMullin, Frank S Lee

Blood (2008) 112 (11): 481.

https://doi.org/10.1182/blood.V112.11.481.481

Published: 2008

NARROW

JAK2 Exon 12 Mutant Allele Burden Study (JETMABS): A European Multicenter Study

Polycythemia-Inducing Mutations In The Erythropoietin Receptor (EPOR): Mechanism and Function Elucidated By EGFR– EPOR Chimeras

First Achievements of MPN&MPNr-EuroNet (COST Action BM0902), a New European Network Dedicated to the Diagnosis of Myeloproliferative Neoplasms and Hereditary Erythrocytosis and Thrombocytosis

The JAK2 46/1 Haplotype Predisposes to Myeloproliferative Neoplasms Characterized by Diverse Mutations.

HIF-2alpha Associated Familial Erythrocytosis Supports the PHD2-HIF- 2alpha-VHL Axis as the Major Regulator of Erythropoietin Production

Email alerts

ASH Publications

American Society of Hematology

JAK2 Exon 12 Mutant Allele Burden Study (JETMABS): A European Multicenter Study

Polycythemia-Inducing Mutations In The Erythropoietin Receptor (EPOR): Mechanism and Function Elucidated By EGFR– EPOR Chimeras

First Achievements of MPN&MPNr-EuroNet (COST Action BM0902), a New European Network Dedicated to the Diagnosis of Myeloproliferative Neoplasms and Hereditary Erythrocytosis and Thrombocytosis

The JAK2 46/1 Haplotype Predisposes to Myeloproliferative Neoplasms Characterized by Diverse Mutations.

HIF-2alpha Associated Familial Erythrocytosis Supports the PHD2-HIF- 2alpha-VHL Axis as the Major Regulator of Erythropoietin Production

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only